×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
返回 Agenda
Session 4: FDA Plenary: Electronic Submissions Update
Session Chair(s)
Jonathan Resnick, PMP
Project Management Officer, OBI, OSP, CDER
FDA, United States
Session 4: FDA Plenary
Learning Objective : At the conclusion of this session, participants should be able to:
- Prepare for eCTD v4.0
- Identify content that may be submitted via CDER’s NextGen Portal
- Describe benefits of PQ/CMC submission data standardization
- Identify tops reasons a submission containing study data fails an eCTD validation
Speaker(s)
ECTD v4.0 Implementation Update
Jonathan Resnick, PMP
FDA, United States
Project Management Officer, OBI, OSP, CDER
![Lina Cong, MS](/_Images/member/Generic_Image_Missing-Profile.jpg)
Study Data Technical Rejection Criteria Update
Lina Cong, MS
FDA, United States
Senior Health Informatics Officer, OBI, CDER
Standardizing Quality Submissions and Assessments: PQ/CMC and KASA
Norman Schmuff, PhD
FDA, United States
Associate Director for Science, OPMA, OPQ
CDER NextGen Portal
Seyoum Senay, MS
FDA, United States
Supervisory Operations Research Analyst, CDER/OBI